Huarong Zhang

Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ceritinib inhibits growth and ACTH production of PitNETs: Insights from patient-derived organoids.

Ceritinib inhibits growth and ACTH production of PitNETs: Insights from patient-derived organoids.

Journal: Pharmacological research

Published: June 18, 2025

A Patient-Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery.

A Patient-Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 02, 2025

Oncolytic viruses: advanced strategies in cancer therapy.

Oncolytic viruses: advanced strategies in cancer therapy.

Journal: Signal transduction and targeted therapy

Published: November 06, 2024

Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF-1R-AKT and ERK Signaling Pathways.

Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF-1R-AKT and ERK Signaling Pathways.

Journal: Glia

Published: May 26, 2024

Factor analysis and subtyping significance of CTNNB1 gene mutation detection in adamantinomatous craniopharyngioma.

Factor analysis and subtyping significance of CTNNB1 gene mutation detection in adamantinomatous craniopharyngioma.

Journal: Genes & diseases

Published: July 19, 2023

Inhibition of integrated stress response protects against lipid-induced senescence in hypothalamic neural stem cells in adamantinomatous craniopharyngioma.

Inhibition of integrated stress response protects against lipid-induced senescence in hypothalamic neural stem cells in adamantinomatous craniopharyngioma.

Journal: Neuro-oncology

Published: December 01, 2022

Tumor-selective Blockade of CD47 Signaling with CD47 Antibody for Enhanced Anti-tumor Activity in Malignant Meningioma.

Tumor-selective Blockade of CD47 Signaling with CD47 Antibody for Enhanced Anti-tumor Activity in Malignant Meningioma.

Journal: Current neuropharmacology

Published: May 10, 2022

Expression of Insulin-Like Growth Factor Type 1 Receptor Is Linked to Inflammation in Adamantinomatous Craniopharyngioma.

Expression of Insulin-Like Growth Factor Type 1 Receptor Is Linked to Inflammation in Adamantinomatous Craniopharyngioma.

Journal: Neuroendocrinology

Published: July 24, 2021

CD47 promotes the proliferation and migration of adamantinomatous craniopharyngioma cells by activating the MAPK/ERK pathway, and CD47 blockade facilitates microglia-mediated phagocytosis.

CD47 promotes the proliferation and migration of adamantinomatous craniopharyngioma cells by activating the MAPK/ERK pathway, and CD47 blockade facilitates microglia-mediated phagocytosis.

Journal: Neuropathology and applied neurobiology

Published: July 01, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026